99 related articles for article (PubMed ID: 37803246)
1. The role of [
Civan C; Kuyumcu S; Has Simsek D; Sanli O; Isik EG; Ozkan ZG; Hurdogan O; Sanli Y
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):852-861. PubMed ID: 37803246
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma.
Guo C; Liu Y; Yang H; Xia Y; Li X; Chen L; Feng Y; Zhang Y; Chen Y; Huang Z
Br J Radiol; 2024 Mar; 97(1156):859-867. PubMed ID: 38290775
[TBL] [Abstract][Full Text] [Related]
3. Head-to-head comparison of [
Ji M; Ma G; Liu C; Gu B; Du X; Ou X; Xu X; Song S; Yang Z
Cancer Imaging; 2024 May; 24(1):56. PubMed ID: 38702821
[TBL] [Abstract][Full Text] [Related]
4.
Sahin E; Kus T; Aytekin A; Uzun E; Elboga U; Yilmaz L; Cayirli YB; Okuyan M; Cimen V; Cimen U
J Nucl Med; 2024 Apr; 65(4):512-519. PubMed ID: 38485276
[TBL] [Abstract][Full Text] [Related]
5. 68 Ga-FAPI-04 PET/CT for the Evaluation of Cholangiocarcinoma : Comparison With 18 F-FDG PET/CT and Abdominal 68 Ga-FAPI-04 PET/MR.
Zhang Z; Cheng C; Jiang H; Pan G; Yu Y; Jin G; Zuo C
Clin Nucl Med; 2024 May; 49(5):409-418. PubMed ID: 38465929
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of
Chen X; Wang S; Lai Y; Wang G; Wei M; Jin X; Ding J; Zhang Y; Shi Y; Wang F; Zhu H; Yang Z; Wang X
J Nucl Med; 2023 Sep; 64(9):1399-1405. PubMed ID: 37385675
[TBL] [Abstract][Full Text] [Related]
7. Head to head comparison of
Gao C; Liu H; Zhou L; Huang W; Liu X
Hell J Nucl Med; 2024; 27(1):35-45. PubMed ID: 38629816
[TBL] [Abstract][Full Text] [Related]
8.
Li C; Chen Q; Tian Y; Chen J; Xu K; Xiao Z; Zhong J; Wu J; Wen B; He Y
J Nucl Med; 2024 Apr; 65(4):527-532. PubMed ID: 38453362
[TBL] [Abstract][Full Text] [Related]
9. Impact of maximum standardized uptake value (SUVmax) evaluated by 18-Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG-PET/CT) on survival for patients with advanced renal cell carcinoma: a preliminary report.
Namura K; Minamimoto R; Yao M; Makiyama K; Murakami T; Sano F; Hayashi N; Tateishi U; Ishigaki H; Kishida T; Miura T; Kobayashi K; Noguchi S; Inoue T; Kubota Y; Nakaigawa N
BMC Cancer; 2010 Dec; 10():667. PubMed ID: 21129184
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of
Arak H; Elboga U; Cayirli YB; Aytekin A
Ann Nucl Med; 2024 Apr; ():. PubMed ID: 38684594
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the Patterns of FAPI Uptake in the Shoulder Joint: a Preliminary Study Comparing with FDG Uptake in Oncological Studies.
Matsusaka Y; Werner RA; Serfling SE; Buck AK; Kosmala A; Sasaki T; Weich A; Higuchi T
Mol Imaging Biol; 2024 Apr; 26(2):294-300. PubMed ID: 38177615
[TBL] [Abstract][Full Text] [Related]
12. Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [
Kosmala A; Duell J; Schneid S; Serfling SE; Higuchi T; Weich A; Lapa C; Hartrampf PE; Raderer M; Einsele H; Buck AK; Topp MS; Schlötelburg W; Werner RA
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):749-755. PubMed ID: 37943339
[TBL] [Abstract][Full Text] [Related]
13. Physiological Uptake Characteristics of Breast on
Zhang Y; Zhou Y; Tian R; Su M
Mol Imaging Biol; 2023 Dec; 25(6):1045-1053. PubMed ID: 37945972
[TBL] [Abstract][Full Text] [Related]
14.
Lanzafame H; Mavroeidi IA; Pabst KM; Desaulniers M; Ingenwerth M; Hirmas N; Kessler L; Nader M; Bartel T; Leyser S; Barbato F; Schuler M; Bauer S; Siveke JT; Herrmann K; Hamacher R; Fendler WP
J Nucl Med; 2024 May; ():. PubMed ID: 38724279
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Potential of Supplemental Static and Dynamic
Röhrich M; Daum J; Gutjahr E; Spektor AM; Glatting FM; Sahin YA; Buchholz HG; Hoppner J; Schroeter C; Mavriopoulou E; Schlamp K; Grott M; Eichhorn F; Heußel CP; Kauczor HU; Kreuter M; Giesel F; Schreckenberger M; Winter H; Haberkorn U
J Nucl Med; 2024 Apr; ():. PubMed ID: 38604763
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 68Ga-FAPI-04 PET/CT with 18F-FDG PET/CT for diagnosis and staging of gastric and colorectal cancer.
Wang B; Zhao X; Liu Y; Zhang Z; Chen X; Jing F; Chen X; Hua Y; Zhao J
Nucl Med Commun; 2024 Apr; ():. PubMed ID: 38686487
[TBL] [Abstract][Full Text] [Related]
17. Comparison of [
Liu M; Chen X; Ding H; Shu Q; Zheng Y; Chen Y; Cai L
Mol Imaging Biol; 2024 Apr; ():. PubMed ID: 38627276
[TBL] [Abstract][Full Text] [Related]
18. Benign lesions with
Shu Q; Wang Y; Deng M; Chen X; Liu M; Cai L
Br J Radiol; 2023 Mar; 96(1144):20220994. PubMed ID: 36715164
[TBL] [Abstract][Full Text] [Related]
19. [
Unterrainer LM; Eismann L; Lindner S; Gildehaus FJ; Toms J; Casuscelli J; Holzgreve A; Kunte SC; Cyran CC; Menold P; Karl A; Unterrainer M; Ledderose ST; Stief CG; Bartenstein P; Kretschmer A; Schulz GB
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1786-1789. PubMed ID: 38236427
[TBL] [Abstract][Full Text] [Related]
20. A head-to-head comparison of [
Zheng J; Wang G; Ru Q; Yang Y; Su L; Lv W; Ke C; Wang P; Liu X; Zhang L; Liu F; Miao W
Eur J Nucl Med Mol Imaging; 2024 May; ():. PubMed ID: 38724654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
